From Cracking Codes to Creating Cures: Leveraging Libraries to Learn the Language of T Cells
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
Tag: immunotherapy
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and...
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...